51
Grand Pharma
512.HK·HKEXBeijing CNFounded 19995,000 employees
Small CappharmaPublicCNSOncology
Platform: CNS Oncology
Market Cap
$1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (512.HK)
Loading 512.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tezevorutinib | 512-5678 | Phase 1/2 | 2 | RET | DravetMDS | ||
| Polalemzoparlimab | 512-2136 | Phase 1 | 2 | WEE1 | NASHPompe |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Grand Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)